DVAX

Dynavax Technologies Corporation

12.75 USD
+0.31 (+2.49%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Dynavax Technologies Corporation stock is down -7.27% since 30 days ago. The next earnings date is Apr 30, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 20 February’s closed higher than January. In the last 9 Unusual Options Trades, there were 4 PUTs, 5 CALLs. 0% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
04 Jan 14:44 19 Jan, 2024 14.00 PUT 1000 457
09 Jan 14:42 17 Jan, 2025 12.00 CALL 100 81
16 Jan 16:05 17 Jan, 2025 15.00 PUT 169 6
19 Jan 19:13 17 Jan, 2025 8.00 CALL 50 193
22 Jan 18:33 19 Jul, 2024 15.00 CALL 250 84
22 Jan 20:42 17 Jan, 2025 17.00 CALL 500 211
23 Jan 19:32 17 Jan, 2025 15.00 PUT 169 175
08 Feb 18:21 17 Jan, 2025 17.00 CALL 323 673
20 Feb 17:17 15 Mar, 2024 12.00 PUT 586 89

About Dynavax Technologies Corporation

The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in the vaccine. The company was formerly known as Double Helix Corporation.